Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach
(1) Background: Prostate-specific membrane antigen (PSMA) has been extensively studied in the last decade. It became a promising biological target in the diagnosis and therapy of PSMA-expressing cancer diseases. Although there are several radiolabeled PSMA inhibitors available, the search for new co...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a9eb4683b79f4443a8fc6edd6be9f631 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|